{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:43:15Z","timestamp":1792784595525,"version":"4.5.0"},"reference-count":37,"publisher":"American Chemical Society (ACS)","issue":"19","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Research B.C.","id":[{"id":"https:\/\/ror.org\/059qgvg50","id-type":"ROR","asserted-by":"crossref"}]},{"name":"GlycoNet"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,6]]},"abstract":"<jats:title>Conspectus<\/jats:title>\n                  <jats:p>Type 2 diabetes is a disease that is rapidly expanding across the world with global cases quadrupling since 1990 and now comprising over 800 million people, the majority of whom are in low- and middle-income countries (Zhou et al.Lancet2024, 404, 2077\u20132093.). The poor control of blood glucose levels that lies at the heart of this disease leads to debilitating complications such as renal failure, vision loss, and amputations and has associations with heart disease and a host of other conditions. Oral drugs that control blood glucose levels and can slow disease progression and reduce the risks are available. Among these are the \u03b1-glucosidase inhibitors acarbose and miglitol that function in the gut to slow the breakdown of starch and of oligosaccharides such as sucrose. However, gastrointestinal side effects such as discomfort and diarrhea frequently cause patients to discontinue treatment, highlighting the need for improved, cost-effective alternatives. Our approach has been to develop selective inhibitors of human pancreatic \u03b1-amylase (HPA) that shut down digestion of starch while sparing oligosaccharide breakdown, thereby lowering blood glucose without causing gastrointestinal discomfort.<\/jats:p>\n                  <jats:p>In this Account, we present the approaches we have taken to identify potent and selective inhibitors of HPA based upon our earlier determinations of the three-dimensional structure and catalytic mechanism of this key digestive enzyme. Our screens of natural product extract libraries produced two particularly interesting hits. One is the natural product Montbretin A (MbA) isolated from the corms of the common Crocosmia garden flower. Through a series of fragmentation studies, in conjunction with X-ray crystallographic analysis of complexes of MbA with HPA, we identified the core inhibitory component of this (Ki = 8 nM) glycosylated acyl flavonoid comprising a pair of \u03c0-stacked phenolic moieties that engage the essential active site carboxylic acids in HPA. Animal studies have shown the efficacy and safety of MbA, and human clinical trials are underway. Based upon this information, simpler inhibitors that retain nanomolar potency have been designed and synthesized.<\/jats:p>\n                  <jats:p>Through a separate screen of marine natural product extracts, we identified helianthamide, from the Caribbean sea anemone Stichodactyla helianthus, as a particularly potent (Ki = 10 pM) and stable 44 amino acid peptidic inhibitor of HPA. The structure of its complex with the highly similar porcine pancreatic \u03b1-amylase (PPA) shows it blocking the active site, using two tyrosines and a histidine to engage the catalytic residues, reminiscent of the \u201cphenol sandwich\u201d found with MbA while deriving considerable additional affinity from the burial of surface area.<\/jats:p>\n                  <jats:p>Finally, we used mRNA display methods to screen large cyclic peptide libraries using the RaPID (Random nonstandard Peptide Integrated Discovery) system in collaboration with the Suga lab. Screening this cyclic peptide library, comprising \u223c1012 peptides, yielded a 9-amino acid lariat peptide that is a potent (Ki = 7 nM) and selective inhibitor of HPA. Structural studies of the complex revealed once again a motif in which two tyrosines, separated by a proline, engage the active site residues. Thus, through screening of three completely distinct libraries, natural products from terrestrial and marine sources, as well as a large cyclic peptide library, a very similar inhibitory motif has been recovered in each case but from different classes of molecules\u2013essentially a case of convergent inhibitor evolution.<\/jats:p>","DOI":"10.1021\/acs.accounts.6c00510","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:01:18Z","timestamp":1789761678000},"page":"3235-3244","source":"Crossref","is-referenced-by-count":0,"title":["Discovery,\nDesign, and Evaluation of Nanomolar to\nPicomolar Inhibitors of Human Pancreatic \u03b1-Amylase for\nControl of Postprandial Blood Glucose Levels"],"prefix":"10.1021","volume":"59","author":[{"given":"Yuqing","family":"Tian","sequence":"first","affiliation":[{"name":"University of British Columbia , , , ,","place":["Vancouver, B.C., Canada, V6T1Z1"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajneesh","family":"Bains","sequence":"additional","affiliation":[{"name":"University of British Columbia , , , ,","place":["Vancouver, B.C., Canada, V6T1Z1"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6722-5701","authenticated-orcid":true,"given":"Stephen G","family":"Withers","sequence":"additional","affiliation":[{"name":"University of British Columbia , , , ,","place":["Vancouver, B.C., Canada, V6T1Z1"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"9","key":"2026100608062746000_cit1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nchembio.1865","article-title":"The amylase\ninhibitor montbretin A reveals a new glycosidase\ninhibition motif","volume":"11","author":"Williams","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"2026100608062746000_cit2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1021\/acscentsci.5b00399","article-title":"Potent\nhuman alpha-amylase inhibition by the\nbeta-defensin-like protein helianthamide","volume":"2","author":"Tysoe","year":"2016","journal-title":"ACS\nCent. Sci."},{"issue":"48","key":"2026100608062746000_cit3","doi-asserted-by":"publisher","first-page":"11073","DOI":"10.1039\/C9SC02610J","article-title":"Synthesis of montbretin A analogues\nyields potent competitive inhibitors of human pancreatic \u03b1-amylase","volume":"10","author":"Tysoe","year":"2019","journal-title":"Chem. Sci."},{"issue":"3","key":"2026100608062746000_cit4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.chembiol.2017.02.001","article-title":"Rapid discovery of\npotent and selective glycosidase-inhibiting de\nnovo peptides","volume":"24","author":"Jongkees","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"2026100608062746000_cit5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4239\/wjd.v7.i1.1","article-title":"Milestones\nin the history of diabetes mellitus: The\nmain contributors","volume":"7","author":"Karamanou","year":"2016","journal-title":"World J. Diabetes"},{"issue":"10467","key":"2026100608062746000_cit6","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and\ntreatment from 1990 to 2022: a pooled analysis of 1108 population-representative\nstudies with 141 million participants","volume":"404","author":"Zhou","year":"2024","journal-title":"Lancet"},{"key":"2026100608062746000_cit7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108762","article-title":"Dual \u03b1-amylase\nand \u03b1-glucosidase inhibitors: recent progress from natural and\nsynthetic resources","volume":"163","author":"Jha","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"D1","key":"2026100608062746000_cit8","doi-asserted-by":"publisher","first-page":"D571","DOI":"10.1093\/nar\/gkab1045","article-title":"The carbohydrate-active\nenzyme database: functions\nand literature","volume":"50","author":"Drula","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"2026100608062746000_cit9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1006\/jmbi.1993.1221","article-title":"Isolation, crystallization and preliminary\ndiffraction analyses of human pancreatic alpha-amylase","volume":"230","author":"Burk","year":"1993","journal-title":"J. Mol. Biol."},{"issue":"3","key":"2026100608062746000_cit10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1110\/ps.8.3.635","article-title":"Cloning,\nmutagenesis,\nand structural analysis of human pancreatic alpha-amylase expressed\nin Pichia pastoris","volume":"8","author":"Rydberg","year":"1999","journal-title":"Protein Sci."},{"issue":"45","key":"2026100608062746000_cit11","doi-asserted-by":"publisher","first-page":"26778","DOI":"10.1074\/jbc.270.45.26778","article-title":"Mechanism-based\ninhibition of yeast\nalpha-glucosidase and human pancreatic alpha-amylase by a new class\nof inhibitors. 2-Deoxy-2,2-difluoro-alpha-glycosides","volume":"270","author":"Braun","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"16","key":"2026100608062746000_cit12","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1021\/bi9921182","article-title":"Subsite\nmapping of the human pancreatic \u03b1-amylase active site through\nstructural, kinetic, and mutagenesis techniques","volume":"39","author":"Brayer","year":"2000","journal-title":"Biochemistry"},{"issue":"9","key":"2026100608062746000_cit13","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/pro.5560040908","article-title":"The structure of human pancreatic alpha-amylase at\n1.8 angstrom resolution and comparisons with related enzymes","volume":"4","author":"Brayer","year":"1995","journal-title":"Protein Sci."},{"issue":"8","key":"2026100608062746000_cit14","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1021\/acschembio.9b00290","article-title":"Folding then binding vs folding through binding in\nmacrocyclic peptide inhibitors of human pancreatic \u03b1-amylase","volume":"14","author":"Goldbach","year":"2019","journal-title":"Acs Chem. Biol."},{"issue":"13","key":"2026100608062746000_cit15","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1021\/bi011821z","article-title":"Mechanistic\nanalyses of catalysis in human pancreatic \u03b1-amylase: Detailed\nkinetic and structural studies of mutants of three conserved carboxylic\nacids","volume":"41","author":"Rydberg","year":"2002","journal-title":"Biochemistry"},{"issue":"8","key":"2026100608062746000_cit16","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/1873-3468.12143","article-title":"Glucosyl epi-cyclophellitol\nallows mechanism-based inactivation and structural analysis of human\npancreatic \u03b1-amylase","volume":"590","author":"Caner","year":"2016","journal-title":"FEBS Lett."},{"issue":"45","key":"2026100608062746000_cit17","doi-asserted-by":"publisher","first-page":"10752","DOI":"10.1021\/bi901400p","article-title":"Directed\n\u201cin situ\u201d inhibitor elongation as a strategy To structurally\ncharacterize the covalent glycosyl-enzyme intermediate of human pancreatic\n\u03b1-amylase","volume":"48","author":"Zhang","year":"2009","journal-title":"Biochemistry"},{"issue":"2","key":"2026100608062746000_cit18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bbapap.2003.07.004","article-title":"Proteinaceous\n\u03b1-amylase inhibitors","volume":"1696","author":"Svensson","year":"2004","journal-title":"Biochim. Biophys.\nActa, Proteins Proteomics"},{"issue":"3","key":"2026100608062746000_cit19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/cbic.200700470","article-title":"The search\nfor novel\nhuman pancreatic \u03b1-amylase inhibitors: High-throughput screening\nof terrestrial and marine natural product extracts","volume":"9","author":"Tarling","year":"2008","journal-title":"ChemBioChem."},{"issue":"1","key":"2026100608062746000_cit20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1196\/annals.1314.033","article-title":"Psychosocial\nstress-induced activation of salivary alpha-amylase: An indicator\nof sympathetic activity?","volume":"1032","author":"Rohleder","year":"2004","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"9","key":"2026100608062746000_cit21","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nchembio.1888","article-title":"A phenol sandwich fights diabetes","volume":"11","author":"Bernardi","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"2026100608062746000_cit22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11010-015-2599-4","article-title":"Glucose lowering effect of montbretin\nA in zucker diabetic fatty rats","volume":"411","author":"Yuen","year":"2016","journal-title":"Mol. Cell.\nBiochem."},{"issue":"8","key":"2026100608062746000_cit23","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1105\/tpc.18.00406","article-title":"Discovery of UDP-glycosyltransferases\nand BAHD-acyltransferases involved in the biosynthesis of the antidiabetic\nplant metabolite montbretin A","volume":"30","author":"Irmisch","year":"2018","journal-title":"Plant Cell"},{"issue":"1","key":"2026100608062746000_cit24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1104\/pp.20.00522","article-title":"Complete biosynthesis\nof the anti-diabetic plant metabolite montbretin A","volume":"184","author":"Irmisch","year":"2020","journal-title":"Plant Physiol."},{"issue":"3","key":"2026100608062746000_cit25","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/tpj.16528","article-title":"Improved production\nof the anti-diabetic metabolite montbretin A in Nicotiana benthamiana:\ndiscovery, characterization, and use of Crocosmia shikimate shunt\ngenes","volume":"117","author":"Kruse","year":"2024","journal-title":"Plant J."},{"issue":"39","key":"2026100608062746000_cit26","doi-asserted-by":"publisher","first-page":"7977","DOI":"10.1039\/D3OB01051A","article-title":"Branched\nmontbretin A mimics allow\nderivatisation and potent amylase inhibition","volume":"21","author":"Calvert","year":"2023","journal-title":"Org. Biomol. Chem."},{"key":"2026100608062746000_cit27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116451","article-title":"Human \u03b2-defensins:\nThe multi-functional natural peptide","volume":"227","author":"Zhao","year":"2024","journal-title":"Biochem.\nPharmacol."},{"issue":"2","key":"2026100608062746000_cit28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0005-2744(69)90420-3","article-title":"Kinetics\nof the reversible inhibition of enzyme-catalysed reactions by tight-binding\ninhibitors","volume":"185","author":"Morrison","year":"1969","journal-title":"Biochim. Biophys. Acta, Enzymol."},{"issue":"10","key":"2026100608062746000_cit29","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.3390\/biomedicines11102682","article-title":"Bioprospecting\nof sea anemones (Cnidaria, Anthozoa, Actiniaria) for \u03b2-defensin-like\n\u03b1-amylase inhibitors","volume":"11","author":"Popkova","year":"2023","journal-title":"Biomedicines"},{"issue":"11","key":"2026100608062746000_cit30","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1002\/pro.5560061102","article-title":"Structure of a pancreatic\nalpha-amylase bound to a substrate analogue at 2.03 A resolution","volume":"6","author":"Qian","year":"1997","journal-title":"Protein Sci."},{"issue":"37","key":"2026100608062746000_cit31","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.1021\/acs.biochem.8b00825","article-title":"Structural dissection\nof helianthamide reveals the\nbasis of its potent inhibition of human pancreatic \u03b1-amylase","volume":"57","author":"Tysoe","year":"2018","journal-title":"Biochemistry"},{"issue":"18","key":"2026100608062746000_cit32","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1021\/acs.accounts.1c00391","article-title":"The RaPID platform\nfor the discovery of pseudo-natural macrocyclic\npeptides","volume":"54","author":"Goto","year":"2021","journal-title":"Acc. Chem. Res."},{"issue":"3","key":"2026100608062746000_cit33","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1432-1033.1984.tb08221.x","article-title":"Tendamistat\n(HOE 467), a tight-binding alpha-amylase inhibitor from Streptomyces\ntendae 4158. Isolation, biochemical properties","volume":"141","author":"Ve\u0301rtesy","year":"1984","journal-title":"Eur. J. Biochem."},{"issue":"7","key":"2026100608062746000_cit34","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.2174\/0929867329666211222164545","article-title":"Sugar-derived\namidines\nand congeners: structures, glycosidase inhibition and applications","volume":"29","author":"Ble\u0301riot","year":"2022","journal-title":"Curr. Med. Chem."},{"issue":"22","key":"2026100608062746000_cit35","doi-asserted-by":"publisher","first-page":"11194","DOI":"10.1021\/acs.chemrev.8b00369","article-title":"Enzymatic\ntransition states and drug design","volume":"118","author":"Schramm","year":"2018","journal-title":"Chem. Rev."},{"issue":"1","key":"2026100608062746000_cit36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s13659-023-00424-w","article-title":"Flavonoids\nas dual-target inhibitors against alpha-glucosidase\nand alpha-amylase: a systematic review of in vitro studies","volume":"14","author":"Lam","year":"2024","journal-title":"Nat. Prod. Bioprospect."},{"issue":"1","key":"2026100608062746000_cit37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1134\/S1607672919060097","article-title":"Magnificamide is a new effective\nmammalian \u03b1-amylase inhibitor","volume":"489","author":"Sintsova","year":"2019","journal-title":"Dokl. Biochem.\nBiophys."}],"container-title":["Accounts of Chemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.accounts.6c00510","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/59\/19\/3235\/68559795\/acs.accounts.6c00510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/achre4\/article-pdf\/59\/19\/3235\/68559795\/acs.accounts.6c00510.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:09:28Z","timestamp":1791292168000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/achre4\/article\/59\/19\/3235\/5433018\/Discovery-Design-and-Evaluation-of-Nanomolar-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":37,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,9,18]]},"published-print":{"date-parts":[[2026,10,6]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.accounts.6c00510","relation":{},"ISSN":["0001-4842","1520-4898"],"issn-type":[{"value":"0001-4842","type":"print"},{"value":"1520-4898","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}